PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by MMIT, an independent national survey entity. For the fourth quarter of 2020, PANTHERx obtained the highest Net Promoter Score (NPS) among all pharmacies surveyed. Net Promoter Score (NPS) is compiled by asking patients, on a […]

What is Rare Disease Day? As scientific breakthroughs have emerged and modern forms of communication have connected patients, specialists, policy makers, activists, and support organizations across the word, the Rare Disease Community has grown and so has its passion to raise awareness in support of rare disease research and patient advocacy. In 2008, EURORDIS, a […]

PANTHERx is proud to join the Centene family of companies. Through this transaction, we are reaffirming our relentless commitment to transforming lives and removing barriers for individuals living with complex and rare diseases. Read the official press release.

Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Alnylam Pharmaceuticals, the leading RNAi therapeutics company, as a very limited distribution pharmacy partner for new drug OXLUMO™ (lumasiran). The drug has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of primary hyperoxaluria type […]

PANTHERx is pleased to announce the receipt of another Pittsburgh Business Times Best Places to Work Award, adding to a history of success. PANTHERx is not afraid to break molds, be nimble, and reimagine programs for better outcomes. This flexibility has always served the organization well, but it is particularly crucial during this time, when […]